Former Pfizer, BenevolentAI, Incyte, and AMAG executives join to strengthen clinical, technology, financial, and scientific leadership as company scales its AI-native pharma model NEW YORK, Sept. 18, ...

Join the Miguel Delaney: Inside Football newsletter and get behind-the-scenes access and unrivalled insight Join the Miguel Delaney: Inside Football newsletter Ruben Amorim admitted he could not ...

Prostate cancer is one of the most common cancers and the second leading cause of cancer-related death in men worldwide. However, the mechanisms controlling the early stages of prostate cancer ...

Spiritual formation shouldn’t be an attempt to control ministry outcomes—it’s about cultivating space for God to work. I recently read about a spiritual formation program that went terribly wrong. A ...

When high explosives are subjected to sudden shock waves, such as from an impact or detonation, tiny regions of intense heat—called hot spots—form at microstructural defects such as pores. These hot ...

A research team from the University of Göttingen and the Max Planck Institute for Solar System Research (MPS) has discovered another piece in the puzzle of the formation of the moon and water on Earth ...

EXCLUSIVE: Atlanta-based talent agency People Store has rebranded as Formation Talent Agency, brining in veteran agent Lauren Williams to serve as Senior Vice President of Talent amidst this evolution ...

To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min A Dallas-based firm is moving ...

"Illegal formation, offense ... five-yard penalty, repeat the down." That sentence was heard a lot during the opening quarter of Thursday's NFL season opener between the Baltimore Ravens and Kansas ...

June 26 (Reuters) - AI-based drug developer Formation Bio said on Wednesday that it has raised $372 million in a late-stage funding round, with a significant participation from French drugmaker Sanofi ...

Formation Bio, a startup focused on applying AI to drug development with backing from OpenAI CEO Sam Altman, has raised over a quarter-billion dollars to support its ambitious product roadmap.

Megarounds have been few and far between in 2024, but Formation Bio has managed to draw in an impressive $372 million series D as the AI-focused biotech seeks to expand its pipeline. AI companies like ...